Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 3,200 shares at $151.71 ($487K) on 2018-11-26, disclosed to the SEC on 2018-11-28.
Open-market sale of $487k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.71 | 1,556 | $236K | 48.5% |
| 2 | $152.49 | 1,644 | $251K | 51.5% |
| Total | $152.11 avg | 3,200 | $487K | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $426K | — | Filing → |
| LOXO | SELL | 2018-12-12 | $120K | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |